Quantitative determination of regional lesion volume and distribution in children and adults with relapsing- Remitting multiple sclerosis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ghassemi, Rezwan ^a   Narayanan, Sridar ^a   Banwell, Brenda ^b,c   Sled, John G ^b   Shroff, Manohar ^b   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; BRAIN DAMAGE; BRAIN MAPPING; BRAIN STEM; CHILD; CHILDHOOD; DISEASE DURATION; FEMALE; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PONS; QUANTITATIVE ANALYSIS; WHITE MATTER LESION; PATHOLOGY;

ADULT; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 84896109884     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085741     Document Type: Article

References (32)

1. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, et al. (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46: 747-754. (Pubitemid 29518136)
2. Caramanos Z, Francis SJ, Narayanan S, Lapierre Y, Arnold DL (2012) Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis. Arch Neurol 69: 89-95.
3. Banwell B, Bar-Or A, Giovannoni G, Dale RC, Tardieu M (2011) Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol 7: 109-122.
4. Verhey LH, Branson HM, Shroff MM, Callen DJ, Sled JG, et al. (2011) MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol 10: 1065-1073.
5. Yeh EA, Weinstock-Guttman B, Ramanathan M, Ramasamy DP, Willis L, et al. (2009) Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain 132: 3392-3400.
6. Ketelslegers IA, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ (2010) A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology 74: 1412-1415.
7. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
8. Ghassemi R, Antel SB, Narayanan S, Francis SJ, Bar-Or A, et al. (2008) Lesion distribution in children with clinically isolated syndromes. Ann Neurol 63: 401-405. (Pubitemid 351499870)
9. Till C, Ghassemi R, Aubert-Broche B, Kerbrat A, Collins DL, et al. (2011) MRI correlates of cognitive impairment in childhood-onset multiple sclerosis. Neuropsychology 25: 319-332.
10. Krupp LB, Banwell B, Tenembaum S (2007) Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68: S7-12.
11. Poser CM, Paty DW, Scheinberg L, McDonald WI, Floyd AD, et al. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Annals of Neurology 13: 227-231. (Pubitemid 13158528)
12. Gedamu EL, Collins DL, Arnold DL (2008) Automated quality control of brain MR images. J Magn Reson Imaging 28: 308-319.
13. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17: 87-97. (Pubitemid 128742012)
14. Collins DL, Neelin P, Peters TM, Evans AC (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assis Tomogr 18: 192-205. (Pubitemid 24100002)
15. Nyul LG, Udupa JK (1999) On standardizing the MR image intensity scale. Magn Reson Med 42: 1072-1081.
16. Francis SJ (2004) Automatic lesion identification in MRI of multiple sclerosis patients. M. Sc. Thesis, McGill University, Montreal, Canada.
17. Collins DL, Evans AC (1997) ANIMAL: Validation and Applications of Non-Linear Registration-Based Segmentation. International Journal of Pattern Recognition and Artificial Intelligence 11: 1271-1294. (Pubitemid 127624470)
18. Afifi AA, Kotlerman JB, Ettner SL, Cowan M (2007) Methods for improving regression analysis for skewed continuous or counted responses. Annu Rev Public Health 28: 95-111. (Pubitemid 46833335)
19. Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, et al. (1997) Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 41: 385-391. (Pubitemid 27114050)
20. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846. (Pubitemid 41746873)
21. Steen RG, Ogg RJ, Reddick WE, Kingsley PB (1997) Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence. AJNR Am J Neuroradiol 18: 819-828. (Pubitemid 28529907)
22. Lenroot RK, Giedd JN (2006) Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev 30: 718-729. (Pubitemid 44292283)
23. Paus T, Collins DL, Evans AC, Leonard G, Pike B, et al. (2001) Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull 54: 255-266. (Pubitemid 32273618)
24. Gallucci M, Caulo M, Cerone G, Masciocchi C (2001) Acquired inflammatory white matter disease. Childs Nerv Syst 17: 202-210. (Pubitemid 32447683)
25. Laribiere A, Miremont-Salame G, Reyre H, Abouelfath A, Liege L, et al. (2005) Surveillance of adverse effects during a vaccination campaign against meningitis C. European journal of clinical pharmacology 61: 907-911. (Pubitemid 41803701)
26. Callen DJ, Shroff MM, Branson HM, Lotze T, Li DK, et al. (2009) MRI in the diagnosis of pediatric multiple sclerosis. Neurology 72: 961-967.
27. Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, et al. (2009) Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol 66: 967-971.
28. Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, et al. (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63: 395-400. (Pubitemid 351499869)
29. Rose JW, Watt HE, White AT, Carlson NG (2004) Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody. Ann Neurol 56: 864-867. (Pubitemid 39578450)
30. O'Connor P, Comi G, Montalban X, Antel J, Radue EW, et al. (2009) Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology 72: 73-79.
31. Comi G, Filippi M, Wolinsky JS (2001) European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. Ann Neurol 49: 290-297. (Pubitemid 32202781)
32. Barkhof F, Polman CH, Radue EW, Kappos L, Freedman MS, et al. (2007) Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. Arch Neurol 64: 1292-1298. (Pubitemid 47403084)